8-K
Current Report
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-18-012030
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading newdirector092120188-kdocu.htm…